As use of GLP-1 weight loss drugs including Wegovy and Ozempic increases, brands are introducing new offerings.
Nasdaq 100, Dow Jones Industrial Average, Dell Technologies Inc, Autodesk Inc. Read Investing.com (Jesse Cohen)'s latest ...